IN8bio (INAB) Short Interest Ratio & Short Volume → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free INAB Stock Alerts $1.34 +0.21 (+18.58%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IN8bio Short Interest DataCurrent Short Interest105,500 sharesPrevious Short Interest179,900 sharesChange Vs. Previous Month-41.36%Dollar Volume Sold Short$119,215.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares44,120,000 sharesFloat Size29,660,000 sharesShort Percent of Float0.36%Today's Trading Volume553,590 sharesAverage Trading Volume204,400 sharesToday's Volume Vs. Average271% Short Selling IN8bio ? Sign up to receive the latest short interest report for IN8bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINAB Short Interest Over TimeINAB Days to Cover Over TimeINAB Percentage of Float Shorted Over Time Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. IN8bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024105,500 shares $119,215.00 -41.4%0.4%0.3 $1.13 4/30/2024179,900 shares $183,498.00 -64.9%0.6%0.5 $1.02 4/15/2024512,000 shares $522,240.00 +892.3%1.8%1.5 $1.02 3/31/202451,600 shares $60,888.00 -39.2%0.2%0.3 $1.18 3/15/202484,800 shares $96,672.00 +296.3%0.3%0.5 $1.14 2/29/202421,400 shares $23,754.00 -47.9%0.1%0 $1.11 Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 2/15/202441,100 shares $45,210.00 -68.1%0.1%0.1 $1.10 1/31/2024129,000 shares $167,700.00 +49.1%0.5%0.2 $1.30 1/15/202486,500 shares $131,480.00 -25.5%0.4%0.1 $1.52 12/31/2023116,100 shares $160,218.00 -77.9%0.7%0.2 $1.38 12/15/2023525,200 shares $1.00 million +490.1%2.9%0.9 $1.91 11/30/202389,000 shares $73,870.00 +222.5%0.4%0.6 $0.83 11/15/202327,600 shares $25,930.20 -51.0%0.1%0.3 $0.94 10/31/202356,300 shares $55,168.37 -0.2%0.3%0.7 $0.98 10/15/202356,400 shares $52,722.72 -43.1%0.3%0.5 $0.93 9/30/202399,100 shares $103,064.00 +166.4%0.5%0.8 $1.04 9/15/202337,200 shares $34,224.00 -57.4%0.2%0.3 $0.92 8/31/202387,300 shares $91,665.00 +90.2%0.4%0.5 $1.05 8/15/202345,900 shares $54,621.00 +81.4%0.2%0.2 $1.19 7/31/202325,300 shares $29,854.00 -70.1%0.1%0.1 $1.18 7/15/202384,700 shares $137,214.00 +22.2%0.6%0 $1.62 6/30/202369,300 shares $106,722.00 -21.9%0.5%0 $1.54 6/15/202388,700 shares $188,044.00 +14.8%0.6%0 $2.12 5/31/202377,300 shares $234,992.00 -43.8%0.6%0 $3.04 5/15/2023137,500 shares $338,250.00 -88.5%1.1%0 $2.46 4/30/20231,190,000 shares $1.74 million +720.7%13.5%0.3 $1.46 4/15/2023145,000 shares $175,450.00 -3.0%1.7%0.1 $1.21 3/31/2023149,500 shares $194,350.00 -9.4%1.7%1.9 $1.30 3/15/2023165,000 shares $219,450.00 -20.6%1.9%1.8 $1.33 2/28/2023207,800 shares $317,934.00 +127.4%2.4%2.2 $1.53 2/15/202391,400 shares $182,800.00 -13.7%1.1%1 $2.00 1/31/2023105,900 shares $243,146.40 -10.3%1.2%1.7 $2.30 1/15/2023118,000 shares $272,580.00 -10.4%1.4%1.9 $2.31 12/30/2022131,700 shares $304,227.00 +28.5%1.5%2 $2.31 12/15/2022102,500 shares $187,575.00 +45.8%1.2%1.7 $1.83 11/30/202270,300 shares $122,322.00 +42.9%0.8%1.1 $1.74 11/15/202249,200 shares $77,736.00 +21.8%0.6%0 $1.58 10/31/202240,400 shares $78,780.00 -9.0%0.5%0 $1.95 10/15/202244,400 shares $89,244.00 -13.3%0.5%0 $2.01 9/30/202251,200 shares $103,424.00 -40.5%0.6%0 $2.02Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. 9/15/202286,100 shares $237,636.00 +154.7%1.0%0.1 $2.76 8/31/202233,800 shares $87,542.00 -17.2%0.8%0 $2.59 8/15/202240,800 shares $77,112.00 +206.8%0.9%0.7 $1.89 7/31/202213,300 shares $33,782.00 +44.6%0.1%1.1 $2.54 7/15/20229,200 shares $19,964.00 -8.9%0.1%0.7 $2.17 6/30/202210,100 shares $22,826.00 -24.6%0.1%0.6 $2.26 6/15/202213,400 shares $28,542.00 -21.2%0.1%0.5 $2.13 5/31/202217,000 shares $37,571.70 +28.8%0.1%0.5 $2.21 5/15/202213,200 shares $36,696.00 +2.3%0.1%0.3 $2.78 4/30/202212,900 shares $30,960.00 -45.6%0.1%0.3 $2.40 4/15/202223,700 shares $82,476.00 +68.1%0.2%0.5 $3.48 3/31/202214,100 shares $46,953.00 +18.5%0.1%0.3 $3.33 3/15/202211,900 shares $35,700.00 -55.4%0.1%0.3 $3.00 2/28/202226,700 shares $112,140.00 -62.3%0.2%0.8 $4.20 2/15/202270,900 shares $303,452.00 +6.5%0.6%2 $4.28 1/31/202266,600 shares $224,442.00 +17.3%0.5%1.8 $3.37 1/15/202256,800 shares $230,040.00 +108.8%N/A1.9 $4.05 12/31/202127,200 shares $119,408.00 No Change0.2%0.9 $4.39 INAB Short Interest - Frequently Asked Questions What is IN8bio's current short interest? Short interest is the volume of IN8bio shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 105,500 shares of INAB short. 0.36% of IN8bio's shares are currently sold short. Learn More on IN8bio's current short interest. What is a good short interest percentage for IN8bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of IN8bio's floating shares are currently sold short. Is IN8bio's short interest increasing or decreasing? IN8bio saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 105,500 shares, a drop of 41.4% from the previous total of 179,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IN8bio's float size? IN8bio currently has issued a total of 44,120,000 shares. Some of IN8bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IN8bio currently has a public float of 29,660,000 shares. How does IN8bio's short interest compare to its competitors? 0.36% of IN8bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IN8bio: T2 Biosystems, Inc. (22.49%), HCW Biologics Inc. (0.01%), Enlivex Therapeutics Ltd. (1.10%), Adicet Bio, Inc. (8.45%), MediWound Ltd. (3.42%), Invivyd, Inc. (9.17%), Coherus BioSciences, Inc. (18.98%), Monte Rosa Therapeutics, Inc. (5.98%), Elevation Oncology, Inc. (10.85%), Scilex Holding (7.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short IN8bio stock? Short selling INAB is an investing strategy that aims to generate trading profit from IN8bio as its price is falling. INAB shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IN8bio? A short squeeze for IN8bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INAB, which in turn drives the price of the stock up even further. How often is IN8bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INAB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TTOO Short Interest HCWB Short Interest ENLV Short Interest ACET Short Interest MDWD Short Interest IVVD Short Interest CHRS Short Interest GLUE Short Interest ELEV Short Interest SCLX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INAB) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.